Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Andy Norman"'
Autor:
Brian O'neill F.F.R.R.C.S.I., Gina Brown, Andrew Wotherspoon, Sarah Burton, Andy Norman, Diana Tait
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2 (2008)
Purpose The benefit of neoadjuvant therapy for tumours above the peritoneal reflection is not clear. The purpose of this study is to demonstrate the feasibility and downstaging of treating locally advanced tumours from high rectum to distal sigmoid w
Externí odkaz:
https://doaj.org/article/f6ad7f3422aa4f918aae6d9ecc9e5287
Autor:
Hendrik-Tobias Arkenau, Geoff Chong, David Cunningham, David Watkins, Bhawna Sirohi, Ian Chau, Andrew Wotherspoon, Andy Norman, Alan Horwich, Estella Matutes
Publikováno v:
Haematologica, Vol 92, Iss 2 (2007)
Novel, effective therapies are needed for peripheral T-cell non-Hodgkin’s lymphoma (PTCL). We treated 16 patients with a combination of gemcitabine, cisplatin and methylprednisolone (GEM-P). Three patients (19%) achieved a complete remission and ei
Externí odkaz:
https://doaj.org/article/24e31318a9e049de99f39b43b63b76a8
Autor:
Andy Norman
When a winning lottery ticket falls into the wrong hands, chaos ensues within South East London's underworld.
Autor:
Andy Norman
Why do people reject science and believe online conspiracy theories? How are people radicalized online and go on to commit acts of violence? Why is our society so politically polarized?Astonishingly irrational ideas are spreading. Covid denial persis
Autor:
Andy Norman
Publikováno v:
Biology & Philosophy. 31:685-704
Why do humans reason? Many animals draw inferences, but reasoning—the tendency to produce and respond to reason-giving performances—is biologically unusual, and demands evolutionary explanation. Mercier and Sperber (Behav Brain Sci 34:57–111, 2
Autor:
Andy Norman
Publikováno v:
Essays in the Philosophy of Humanism. 18:63-88
Autor:
Bhawna Sirohi, David Cunningham, Andy Norman, Kim Last, Ian Chau, Alan Horwich, Jacqui Oates, Geoffrey Chong, Andrew Wotherspoon
Publikováno v:
Hematology. 12:149-153
This is the first report of the combination of gemcitabine, cisplatin and methylprednisolone (GEM-P) with Rituximab (GEM-PR) for diffuse large B-cell lymphoma (DLBCL). Thirty-nine patients with relapsed or refractory DLBCL in this study received GEM-
Autor:
Andrew Wotherspoon, Kim Last, Geoffrey Chong, Yvonne Prior, Tracey Murray, Sheela Rao, Michele Trumper, Andy Norman, David Cunningham, Bhawna Sirohi
Publikováno v:
Blood. 106:939-939
There is currently no standard salvage chemotherapy regimen in patients with relapsed/ refractory DLBCL. We have previously shown that GEM-P is an effective salvage regimen in patients with relapsed/refractory lymphoma; 10 patients in this study had